Antidepressant actions of ketamine: From molecular mechanisms to clinical practice

Lisa M Monteggia, Carlos Zarate

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

In the past decade the emergence of glutamate N-methyl- d-aspartate (NMDA) receptor blockers such as ketamine as fast-acting antidepressants fostered a major conceptual advance by demonstrating the possibility of a rapid antidepressant response. This discovery brings unique mechanistic insight into antidepressant action, as there is a substantial amount of basic knowledge on glutamatergic neurotransmission and how blockade of NMDA receptors may elicit plasticity. The combination of this basic knowledge base and the growing clinical findings will facilitate the development of novel fast acting antidepressants.

Original languageEnglish (US)
Pages (from-to)139-143
Number of pages5
JournalCurrent Opinion in Neurobiology
Volume30
DOIs
StatePublished - Feb 1 2015

Fingerprint

Ketamine
Antidepressive Agents
Knowledge Bases
Synaptic Transmission
Glutamic Acid
aspartic acid receptor

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Antidepressant actions of ketamine : From molecular mechanisms to clinical practice. / Monteggia, Lisa M; Zarate, Carlos.

In: Current Opinion in Neurobiology, Vol. 30, 01.02.2015, p. 139-143.

Research output: Contribution to journalArticle

@article{303b6f7f748e4546bb265ae60b715f65,
title = "Antidepressant actions of ketamine: From molecular mechanisms to clinical practice",
abstract = "In the past decade the emergence of glutamate N-methyl- d-aspartate (NMDA) receptor blockers such as ketamine as fast-acting antidepressants fostered a major conceptual advance by demonstrating the possibility of a rapid antidepressant response. This discovery brings unique mechanistic insight into antidepressant action, as there is a substantial amount of basic knowledge on glutamatergic neurotransmission and how blockade of NMDA receptors may elicit plasticity. The combination of this basic knowledge base and the growing clinical findings will facilitate the development of novel fast acting antidepressants.",
author = "Monteggia, {Lisa M} and Carlos Zarate",
year = "2015",
month = "2",
day = "1",
doi = "10.1016/j.conb.2014.12.004",
language = "English (US)",
volume = "30",
pages = "139--143",
journal = "Current Opinion in Neurobiology",
issn = "0959-4388",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Antidepressant actions of ketamine

T2 - From molecular mechanisms to clinical practice

AU - Monteggia, Lisa M

AU - Zarate, Carlos

PY - 2015/2/1

Y1 - 2015/2/1

N2 - In the past decade the emergence of glutamate N-methyl- d-aspartate (NMDA) receptor blockers such as ketamine as fast-acting antidepressants fostered a major conceptual advance by demonstrating the possibility of a rapid antidepressant response. This discovery brings unique mechanistic insight into antidepressant action, as there is a substantial amount of basic knowledge on glutamatergic neurotransmission and how blockade of NMDA receptors may elicit plasticity. The combination of this basic knowledge base and the growing clinical findings will facilitate the development of novel fast acting antidepressants.

AB - In the past decade the emergence of glutamate N-methyl- d-aspartate (NMDA) receptor blockers such as ketamine as fast-acting antidepressants fostered a major conceptual advance by demonstrating the possibility of a rapid antidepressant response. This discovery brings unique mechanistic insight into antidepressant action, as there is a substantial amount of basic knowledge on glutamatergic neurotransmission and how blockade of NMDA receptors may elicit plasticity. The combination of this basic knowledge base and the growing clinical findings will facilitate the development of novel fast acting antidepressants.

UR - http://www.scopus.com/inward/record.url?scp=84920279509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920279509&partnerID=8YFLogxK

U2 - 10.1016/j.conb.2014.12.004

DO - 10.1016/j.conb.2014.12.004

M3 - Article

C2 - 25562451

AN - SCOPUS:84920279509

VL - 30

SP - 139

EP - 143

JO - Current Opinion in Neurobiology

JF - Current Opinion in Neurobiology

SN - 0959-4388

ER -